Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
PRESS RELEASE CANNIM has today announced a world first as it releases its Jamaican grown medical cannabis for patients in the UK.
LONDON-based Lyphe Group has signed an agreement to acquire Materia for an undisclosed sum, with the new combination expected to have a ‘massively positive effect’ on the industry.
A NEW clinic giving islanders the opportunity to be prescribed medical cannabis is opening its doors in St Martin this week.
LYPHE Group has announced the successful closure of its latest funding round, securing £5m in capital to fund expansion into ‘multiple markets’ across Europe.
At Akanda, Dr. Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation – and the wider industry.
On this episode of BofC Live, we connect with Dean Friday, CEO and Jonathan Nadler, Group Managing Director of LYPHE Group.